Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity (Q39710299)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity |
scientific article |
Statements
1 reference
Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity (English)
1 reference
Alison M Strack
1 reference
Tung M Fong
1 reference
Lauren P Shearman
1 reference
Lin Yan
1 reference
Pei Huo
1 reference
John S Debenham
1 reference
Christina B Madsen-Duggan
1 reference
Julie Lao
1 reference
Richard Z Chen
1 reference
Jing Chen Xiao
1 reference
Chun-Pyn Shen
1 reference
D Sloan Stribling
1 reference
Nancy Tsou
1 reference
Richard G Ball
1 reference
Junying Wang
1 reference
Xinchun Tong
1 reference
Thomas J Bateman
1 reference
Vijay B G Reddy
1 reference
Jeffrey J Hale
1 reference
1 May 2010
1 reference
1 reference
53
1 reference
10
1 reference
4028-4037
1 reference
Identifiers
1 reference
1 reference